Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F0XK6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,060
Award facts
- Contract value 100% obligated
- $33,059.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33,059.89 firm fixed price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pharmaceutical supplies. The contract, awarded December 1, 2025, with an ultimate completion date of December 2, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is registered in the System for Award Management (SAM.gov). This delivery order is issued under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical.
This award is a child contract issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (SPE2DX) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Repatha is a PCSK9 inhibitor used for cholesterol management, and this delivery order fulfills specific pharmaceutical needs within the Defense Health Agency and broader military healthcare system. The contract supports DLA's ongoing pharmaceutical procurement strategy to ensure consistent supply of critical medications to servicemembers and military medical facilities.
Quick answers
Who was awarded contract SPE2DR26F0XK6?
SPE2DR26F0XK6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26F0XK6 worth?
The government has obligated $33,060 on SPE2DR26F0XK6.
Is contract SPE2DR26F0XK6 an order under another contract?
Yes. SPE2DR26F0XK6 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0XK6 competed?
The extent of competition for SPE2DR26F0XK6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award